Top Markets
Coin of the day
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.

TARO
주식 순위 #7354
Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven... Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven pharmaceutical enterprise, specializing in the development, manufacturing, and commercialization of both prescription and over-the-counter medications. Its market reach spans the United States, Canada, Israel, and various other international territories. The company also produces active pharmaceutical ingredients (APIs), primarily for integration into its own finished dosage form products. Its extensive product catalog addresses a broad spectrum of medical conditions and therapeutic areas, encompassing treatments for allergies, pain (analgesic), bacterial and fungal infections (antibacterial, antibiotic, antifungal), seizures (anticonvulsant), nausea (antiemetic), inflammation (anti-inflammatory), cancer (anti-cancer, topical anti-neoplastic), blood clot prevention (antiplatelet agent), fever reduction (antipyretic), cardiovascular issues, central nervous system disorders, hormonal regulation (corticosteroid, endocrine), cosmetic applications, coughs and colds, dermatological complaints, fluid management (diuretic), gastrointestinal problems, constipation (laxative), severe pain (narcotics), neuropathic pain, neuropsychiatric conditions, and sleep/anxiety management (sedative/hypnotic). These pharmaceutical goods are available in numerous formats, including capsules, creams, drops, emulsions, gels (and gel kits), granules, injectables, lotions, oils, ointments, pastes, powders (and powders for solution), rectal suppositories, shampoos, solutions (and solutions for infusion), sprays, suspensions, syrups, tablets, toothpastes and mouthwashes, topical foams, and topical solutions. Taro distributes and sells its products directly to a wide array of clients, such as pharmaceutical wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, other direct purchasers, and various healthcare institutions and private pharmacies. The company was established in 1950, with its main offices situated in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a wholly-owned subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
주가
$42.98
마지막 동기화: 2024-06-21
시가총액
$1.62B
변동 (1일)
0.01%
변동 (1년)
0.00%
국가
IL
거래 Taro Pharmaceutical Industries Ltd. (TARO)

카테고리

Taro Pharmaceutical Industries Ltd. (TARO)의 매출
Mar 2024 기준 매출 TTM: $629.18M
Taro Pharmaceutical Industries Ltd.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $629.18M입니다. 2023년에 회사는 $572.95M의 수익을 올렸으며 이는 2022년의 $561.35M 대비 증가입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Taro Pharmaceutical Industries Ltd.의 수익 기록 (1999 ~ 2026)
매년 말 매출
연도 매출 변화
2026 (TTM) $629.18M 0.00%
2024 $629.18M 9.81%
2023 $572.95M 2.07%
2022 $561.35M 2.25%
2021 $548.97M -14.86%
2020 $644.77M -3.75%
2019 $669.89M 1.21%
2018 $661.91M -24.73%
2017 $879.39M -7.51%
2016 $950.75M 10.18%
2015 $862.94M 13.65%
2014 $759.29M 13.16%
2013 $670.95M 23.55%
2012 $543.08M 38.35%
2010 $392.54M 9.76%
2009 $357.64M 8.69%
2008 $329.04M 2.97%
2007 $319.55M 26.67%
2006 $252.27M -15.27%
2005 $297.74M 4.79%
2004 $284.13M -9.93%
2003 $315.46M 49.10%
2002 $211.58M 40.93%
2001 $150.13M 44.64%
2000 $103.80M 23.88%
1999 $83.79M 0.00%
유사 기업 또는 경쟁사의 매출